Clinical Trial Update: Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for cyclophosphamide and fludarabine followed by autologous lymphocyte infusion and interleukin-2 in refractory or recurrent metastatic mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Melanoma (Skin) | Phase 2 | Status: TERMINATED